305 related articles for article (PubMed ID: 30930440)
81. Dry coating of micronized API powders for improved dissolution of directly compacted tablets with high drug loading.
Han X; Ghoroi C; Davé R
Int J Pharm; 2013 Feb; 442(1-2):74-85. PubMed ID: 22921376
[TBL] [Abstract][Full Text] [Related]
82. Design of Chronomodulated Drug Delivery System of Valsartan: In Vitro Characterization.
Sokar M; Hanafy A; Elkamel A; El-Gamal S
Indian J Pharm Sci; 2015; 77(4):470-7. PubMed ID: 26664064
[TBL] [Abstract][Full Text] [Related]
83. Development of bicarbonate buffer flow-through cell dissolution test and its application in prediction of in vivo performance of colon targeting tablets.
Ikuta S; Nakagawa H; Kai T; Sugano K
Eur J Pharm Sci; 2023 Jan; 180():106326. PubMed ID: 36347443
[TBL] [Abstract][Full Text] [Related]
84. Influence of adjuvants on the dissolution profile of tablets containing high doses of spray-dried extract of Maytenus ilicifolia.
de Souza TP; Bassani VL; González Ortega G; dalla Costa TC; Petrovick PR
Pharmazie; 2001 Sep; 56(9):730-3. PubMed ID: 11593994
[TBL] [Abstract][Full Text] [Related]
85. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
86. Near-infrared spectroscopy as a nondestructive alternative to conventional tablet hardness testing.
Morisseau KM; Rhodes CT
Pharm Res; 1997 Jan; 14(1):108-11. PubMed ID: 9034230
[TBL] [Abstract][Full Text] [Related]
87. Towards a real time release approach for manufacturing tablets using NIR spectroscopy.
Pestieau A; Krier F; Thoorens G; Dupont A; Chavez PF; Ziemons E; Hubert P; Evrard B
J Pharm Biomed Anal; 2014 Sep; 98():60-7. PubMed ID: 24880992
[TBL] [Abstract][Full Text] [Related]
88. Temperature, pH and agitation rate as dissolution test discriminators of zofenopril calcium tablets.
Lozano R; Joseph JM; Kline BJ
J Pharm Biomed Anal; 1994 Feb; 12(2):173-7. PubMed ID: 8003543
[TBL] [Abstract][Full Text] [Related]
89. Real-time monitoring of changes of adsorbed and crystalline water contents in tablet formulation powder containing theophylline anhydrate at various temperatures during agitated granulation by near-infrared spectroscopy.
Otsuka M; Kanai Y; Hattori Y
J Pharm Sci; 2014 Sep; 103(9):2924-2936. PubMed ID: 24832393
[TBL] [Abstract][Full Text] [Related]
90. Formulation and in-vitro evaluation of floating bilayer tablet of lisinopril maleate and metoprolol tartrate.
Ijaz H; Qureshi J; Danish Z; Zaman M; Abdel-Daim M; Hanif M; Waheed I; Mohammad IS
Pak J Pharm Sci; 2015 Nov; 28(6):2019-25. PubMed ID: 26639495
[TBL] [Abstract][Full Text] [Related]
91. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V
Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316
[TBL] [Abstract][Full Text] [Related]
92. Interpolymer complexation between copovidone and carbopol and its effect on drug release from matrix tablets.
Zhang F; Meng F; Wang ZY; Na W
Drug Dev Ind Pharm; 2017 Feb; 43(2):190-203. PubMed ID: 27599027
[TBL] [Abstract][Full Text] [Related]
93. Pinaverium Bromide: Development and Validation of Spectrophotometric Methods for Assay and Dissolution Studies.
Martins DDFC; Florindo LC; Machado AKMDS; Todeschini V; Sangoi MDS
J AOAC Int; 2017 Nov; 100(6):1747-1753. PubMed ID: 28776492
[TBL] [Abstract][Full Text] [Related]
94. Development of a Suitable Dissolution Method for the Combined Tablet Formulation of Atorvastatin and Ezetimibe by RP-LC Method.
Ozkan Cansel K; Ozgur E; Sevinc K; Ayhan S; Ozkan SA; Yalcin O
Curr Drug Deliv; 2016; 13(3):424-32. PubMed ID: 26638976
[TBL] [Abstract][Full Text] [Related]
95. Quantification of pharmaceutical polymorphs and prediction of dissolution rate using theophylline tablet by terahertz spectroscopy.
Hisazumi J; Suzuki T; Nakagami H; Terada K
Chem Pharm Bull (Tokyo); 2011; 59(4):442-6. PubMed ID: 21467671
[TBL] [Abstract][Full Text] [Related]
96. [Quality evaluation of magnesium oxide tablets using acid neutralization test and dissolution test].
Inoue C; Kogure T; Kamata A; Ishihara M; Muraoka R; Tatsumi A; Tanaka K; Takeshita H; Hamaguchi T; Tagawa N; Kobayashi Y; Kadobayashi M
Yakugaku Zasshi; 2007 Dec; 127(12):2085-9. PubMed ID: 18057798
[TBL] [Abstract][Full Text] [Related]
97. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
Zimmer Ł; Kasperek R; Poleszak E
Polim Med; 2014; 44(4):231-5. PubMed ID: 25932904
[TBL] [Abstract][Full Text] [Related]
98. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet.
Mourão SC; da Silva C; Bresolin TM; Serra CH; Porta V
Int J Pharm; 2010 Feb; 386(1-2):201-7. PubMed ID: 19941944
[TBL] [Abstract][Full Text] [Related]
99. Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets.
Belew S; Suleman S; Duguma M; Teshome H; Wynendaele E; Duchateau L; De Spiegeleer B
Malar J; 2020 Apr; 19(1):139. PubMed ID: 32264882
[TBL] [Abstract][Full Text] [Related]
100. Dissolution profiles of drugs from tablets.
Kitamori N; Iga K
J Pharm Sci; 1978 Oct; 67(10):1436-9. PubMed ID: 702298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
